Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years. [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and immunogenicity of an HIV-1 vaccine regimen (UVAX-1107 with adjuvant, followed by UVAX-1107 or UVAX-1197) in healthy ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infections

Drugs mentioned

• UVAX-1107
• UVAX-1197

Snippet

Sponsor: Uvax Bio LLC | Conditions: AIDS/HIV - RelatedDisease Associated With AIDS, Vaccine-Preventable Diseases | EARLY_Phase 1 | Status: COMPLETED